Resident Blog - Gillian Steiger

from The mTOR You Know · host The mTOR You Know

PGY2 SOT Gillian Stiger joins us from the Hospital of the University of Pennsylvania to discuss “Clazakizumab in the treatment of chronic active antibody-mediated kidney transplant rejection: Results from the IMAGINE phase 3, randomized, double-blind, placebo-controlled study”, as well as a discussion on her residency experience with belatacept rapid conversion for a patient with thrombotic microangiopathy associated with tacrolimus.

Episode metadata supplied by the publisher feed · Published May 15, 2026

Embed this episode

Attribution link and audio player

NOW PLAYING

Resident Blog - Gillian Steiger

0:00 11:42

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of The mTOR You Know?

This episode is 11 minutes long.

When was this The mTOR You Know episode published?

This episode was published on May 15, 2026.

Can I download this The mTOR You Know episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!